Levetiracetam: Difference between revisions
 
(11 intermediate revisions by 6 users not shown)
Line 1: Line 1:
==General==
==General==
*Type: Anticonvulsants
*Type: [[Anticonvulsants]]
*Dosage Forms: PO 250, 500, 750, 1000; 500 ER, 750 ER; IV 100/mL
*Dosage Forms: PO 250mg, 500mg, 750mg, 1000mg; 500mg ER, 750mg ER; IV 100mg/mL
*Common Trade Names: Keppra
*Common Trade Names: Keppra


==Adult Dosing==
==Adult Dosing==
*Partial seizures, adjunct  
*[[Status Epilepticus]]
**500-1500 mg PO/IV q12h.  
**20-40mg/kg IV loading dose
***Start 500 q12 or 1000 qd, inc by 1000 mg/day q2wk
*Partial [[seizures]], adjunct  
***Max 3000 mg/day
**500-1500mg PO/IV q12h.  
*Generalized tonic clonic seizures, adjunct
***Start 500 q12 or 1000 QD, inc by 1000mg/day q2wk
**1500 mg PO/IV q12h
***Max 3000mg/day
***Start 500 q12, inc by 1000 mg/day q2wk
*Generalized tonic clonic [[seizures]], adjunct
***Max 3000 mg/day
**1500mg PO/IV q12h or
***Start 500 q12, inc by 1000mg/day q2wk
***Max 3000mg/day


==Pediatric Dosing==
==Pediatric Dosing==
Line 18: Line 20:
**4-15 yo
**4-15 yo
***60mg/kg/day PO divided bid
***60mg/kg/day PO divided bid
***Start 20 mg/kg/day PO divided bid, inc by 20 mg/kg/day q2wk
***Start 20mg/kg/day PO divided bid, inc by 20mg/kg/day q2wk
***Max 3000 mg/day
***Max 3000mg/day
**>16 yo
**>16 yo
***500-1500 mg PO/IV q12h.  
***500-1500mg PO/IV q12h.  
***Start 500 q12 or 1000 qd, inc by 1000 mg/day q2wk
***Start 500 q12 or 1000 QD, inc by 1000mg/day q2wk
***Max 3000 mg/day
***Max 3000mg/day
*Generalized tonic clonic seizures, adjunct
*Generalized tonic clonic seizures, adjunct
**6-15 yo
**6-15 yo
***60mg/kg/day PO divided bid
***60mg/kg/day PO divided bid
***Start 20 mg/kg/day PO divided bid, inc by 20 mg/kg/day q2wk
***Start 20mg/kg/day PO divided bid, inc by 20mg/kg/day q2wk
***Max 3000 mg/day
***Max 3000mg/day
**>16 yo
**>16 yo
***1500 mg PO/IV q12h
***1500mg PO/IV q12h
***Start 500 q12, inc by 1000 mg/day q2wk
***Start 500 q12, inc by 1000mg/day q2wk
***Max 3000 mg/day
***Max 3000mg/day


==Special Populations==
==Special Populations==
Line 39: Line 41:
*Renal Dosing
*Renal Dosing
**Adult
**Adult
***CrCl 50-80: 500-1000mg q12h IR; 1000-2000 mg qd ER
***CrCl 50-80: 500-1000mg q12h IR; 1000-2000mg QD ER
***CrCl 30-50: 250-750 mg q12h IR; 500-1500 mg qd ER
***CrCl 30-50: 250-750mg q12h IR; 500-1500mg QD ER
***CrCl <30: 250-500mg q12h; 500-1000 mg qd ER
***CrCl <30: 250-500mg q12h; 500-1000mg QD ER
***HD: 500-1000 mg q24h IR, do not use ER
***HD: 500-1000mg q24h IR, do not use ER
**Pediatric
**Pediatric
***CrCl <50, IR: dec dose 50%
***CrCl <50, IR: decrease dose 50%
***CrCl 50-80: 1000-2000 mg qd ER
***CrCl 50-80: 1000-2000mg QD ER
***CrCl 30-50: 500-1500 mg qd ER
***CrCl 30-50: 500-1500mg QD ER
***CrCl <30: 500-1000 mg qd ER
***CrCl <30: 500-1000mg QD ER


*Hepatic Dosing: no adjustment
*Hepatic Dosing: no adjustment
Line 67: Line 69:
*Toxic epidermal necrolysis
*Toxic epidermal necrolysis
*Erythema multiforme
*Erythema multiforme
*withdrawal seizures if abrupt d/c
*withdrawal seizures if abrupt discharge


===Common===
===Common===
Line 81: Line 83:
*Nervousness
*Nervousness
*Dizziness
*Dizziness
*Diarrhea
*[[Diarrhea]]
*Behavioral changes
*Behavioral changes
*Irritability
*Irritability
Line 105: Line 107:


==See Also==
==See Also==
[[Anticonvulsants]]
*[[Seizure]]
*[[Anticonvulsants]]
*[[Anticonvulsant levels and reloading]]


==Sources==
==References==
epocrates
epocrates


<references/>
<references/>
[[Category:Drugs]]
[[Category:Pharmacology]] [[Category:Neurology]]

Latest revision as of 13:48, 19 April 2021

General

  • Type: Anticonvulsants
  • Dosage Forms: PO 250mg, 500mg, 750mg, 1000mg; 500mg ER, 750mg ER; IV 100mg/mL
  • Common Trade Names: Keppra

Adult Dosing

  • Status Epilepticus
    • 20-40mg/kg IV loading dose
  • Partial seizures, adjunct
    • 500-1500mg PO/IV q12h.
      • Start 500 q12 or 1000 QD, inc by 1000mg/day q2wk
      • Max 3000mg/day
  • Generalized tonic clonic seizures, adjunct
    • 1500mg PO/IV q12h or
      • Start 500 q12, inc by 1000mg/day q2wk
      • Max 3000mg/day

Pediatric Dosing

  • Partial seizures, adjunct
    • 4-15 yo
      • 60mg/kg/day PO divided bid
      • Start 20mg/kg/day PO divided bid, inc by 20mg/kg/day q2wk
      • Max 3000mg/day
    • >16 yo
      • 500-1500mg PO/IV q12h.
      • Start 500 q12 or 1000 QD, inc by 1000mg/day q2wk
      • Max 3000mg/day
  • Generalized tonic clonic seizures, adjunct
    • 6-15 yo
      • 60mg/kg/day PO divided bid
      • Start 20mg/kg/day PO divided bid, inc by 20mg/kg/day q2wk
      • Max 3000mg/day
    • >16 yo
      • 1500mg PO/IV q12h
      • Start 500 q12, inc by 1000mg/day q2wk
      • Max 3000mg/day

Special Populations

  • Pregnancy Rating: C
  • Lactation: probably safe
  • Renal Dosing
    • Adult
      • CrCl 50-80: 500-1000mg q12h IR; 1000-2000mg QD ER
      • CrCl 30-50: 250-750mg q12h IR; 500-1500mg QD ER
      • CrCl <30: 250-500mg q12h; 500-1000mg QD ER
      • HD: 500-1000mg q24h IR, do not use ER
    • Pediatric
      • CrCl <50, IR: decrease dose 50%
      • CrCl 50-80: 1000-2000mg QD ER
      • CrCl 30-50: 500-1500mg QD ER
      • CrCl <30: 500-1000mg QD ER
  • Hepatic Dosing: no adjustment

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

  • Depression
  • Hostility
  • Aggressive behavior
  • Psychosis
  • Suicidality
  • Leukopenia
  • Neutropenia
  • Drug rash with eosinophilia and systemic sx
  • Stevens-Johnson
  • Toxic epidermal necrolysis
  • Erythema multiforme
  • withdrawal seizures if abrupt discharge

Common

  • Somnolence
  • Asthenia
  • Vomiting
  • Headache
  • URI sx
  • Anorexia
  • Infection
  • Hostility
  • Fatigue
  • Nervousness
  • Dizziness
  • Diarrhea
  • Behavioral changes
  • Irritability
  • Pain
  • Agitation
  • Emotional lability
  • Depression
  • Nausea
  • Vertigo
  • Ataxia
  • Leukopenia
  • Neutropenia
  • Anxiety
  • Confusion
  • Amnesia
  • Alopecia

Pharmacology

  • Half-life: 6-8h
  • Metabolism: hydrolysis minimally
  • Excretion: urine
  • Mechanism of Action: exact mechanism unknown

See Also

References

epocrates


Retrieved from "https://www.wikem.org/w/index.php?title=Levetiracetam&oldid=301820"